Skip to content

Choice of resuscitation fluids in Dengue shock in children.

Comparison of Acetate-based, Lactate-based and Multiple Electrolyte Solution versus saline (MeSLAc trial) in Dengue shock A multicenter randomized controlled trial - MeSLAcD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088778
Enrollment
560
Registered
2025-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A90- Dengue fever [classical dengue]

Interventions

Intervention1: Balanced crystalloids: Plasmalyte or Ringer s lactate or Ringers acetate as resuscitation fluid Control Intervention1: Saline: Saline will be used as resuscitation fluid

Sponsors

All India Institute of Medical Sciences, New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children 2 month to less than 17 years with features of Dengue shock defined as children with probable dengue fever ; a positive test by rapid diagnostic test; and have at least two clinical signs of decreased perfusion with or without hypotension

Exclusion criteria

Exclusion criteria: Children with culture positive sepsis or suspected septic shock Children receiving fluid boluses before enrollment Children with cardiogenic shock. Children whose parents refuse to give an informed consent

Design outcomes

Primary

MeasureTime frame
Proportion of children with Major Adverse Kidney events - new onset or progressive AKI, in-hospital mortality, new renal replacement therapy, or persistent renal dysfunction at 30 daysTimepoint: Within 30 days of enrollment

Secondary

MeasureTime frame
Proportion of children with hyperchloremiaTimepoint: In the first 7 days;Proportion of children attaining shock resolutionTimepoint: In first 24 hours;MortalityTimepoint: Till day 30

Countries

India

Contacts

Public ContactJhuma Sankar

All India Institute of Medical Sciences

jhumasankar@aiims.edu9818399864

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026